Neutralizing Antibodies - The Key Measurement for COVID 19 Immunity | Premier Medical Lab Services
Click for the video's transcript...👇👇👇
👉 While most of the public has either been vaccinated and/or contracted covid-19, patients have a lot of questions about their level of risk…
👉 How do I know if I’m protected?
👉 How do I know if I have a sufficient level of antibodies?
👉 When should I get a booster shot?
👉 I had covid, am I still protected with those antibodies?
👉 As the pandemic evolves with increasing vaccination rates and the circulation of new variants, research that advances our understanding of COVID-19 protective immunity becomes increasingly important.
👉 Neutralizing antibodies block the virus’s ability to infect a host. Several studies have shown that neutralizing antibody level is a good biomarker for the correlate of protection against SARS-CoV-2 infection.
👉 Immune response to infection or vaccination can vary widely between individuals based upon multiple variables.
👉 Over-the-counter antibody tests do not tell the whole story as they do not specifically identify SARS-CoV-2 Neutralizing Antibodies, and they do not quantify the amount present in a person’s sample.
👉 Aditxtscore is a 9-assay COVID-19 antibody test that provides greater precision and more detail about the strength of an individual’s response against the virus.
👉 Aditxtscore measures COVID-19 Neutralizing Antibodies combined with a proprietary algorithm to assess and translate clinical data into meaningful information for individuals.
👉 This test is an important tool to help individuals, their families, and clinicians better understand and manage the relative risk of getting severe COVID-19 symptoms if infected.
👉 PMLS is proud to offer Aditxtscore as part of our comprehensive laboratory testing options.
👉 Contact us today to order your Aditxtscore testing kits.
1 - Bergwerk M, Gonen T, Lustig Y, et al.
COVID-19 breakthrough infections in vaccinated health care workers. N Engl J Med. 2021; 385: 1474-1484
2 - Khoury DS, Cromer D, Reynaldi A, et al.
Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection. Nat Med. 2021; 27: 1205-1211
3 - Feng S, Phillips DJ, White T, et al.
Correlates of protection against symptomatic and asymptomatic SARS-CoV-2 infection. medRxiv. 2021;
*********************************
Video provided by Gnosis Corp.
www.gnosis.team
